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The Department of Public Health’s (DPH) Prescription Drug Monitoring Program (PMP) serves as a repository of data for all prescription drugs dispensed 
statewide, including those prescriptions that are sought after for illicit and non-medical use and thus represent the highest potential for abuse (federal 
Schedules II – V, including certain narcotics, stimulants and sedatives). The PMP also enables prescribers and dispensers to access a patient’s 
prescription history and can be used as a clinical decision-making tool, allowing the provider to have a holistic view of the patient’s medications. 
 
When interpreting PMP county-level data, it is important to emphasize that increases or decreases in a single measure may not indicate an increase or 
decrease in prescription misuse or abuse. Put simply, use does not always equate to abuse. There are many factors that might explain an unusually high 
rate of prescribing in a given area. For instance, an area which contains a large number of residents in long-term care facilities may result in a high rate 
of opioid prescribing. 
 
These datasets inform critical discussions about opioid prescribing, provide an important baseline to better inform future policy decisions and allow the 
state and stakeholders to more meaningfully measure whether policy initiatives are effective. 
 
Effective October 6, 2014, all hydrocodone combination drug (HCD) products (e.g., Vicodin) were reclassified from Schedule III to Schedule II.  This 
reclassification during the last quarter of 2014 makes comparisons over time difficult to interpret. Beginning with CY 2015 data, reports of Schedule II 
products will include all HCD prescriptions.  
 
Individuals with activity of concern "thresholds" for this report are based on a 3-month time period. MDPH has previously released annual county-level 
reports that provide thresholds based on a 12-month time period. Although the numbers (or rates) generated may appear to be comparable, they 
represent different time periods and are NOT an apples-to-apples comparison. The results are only comparable when the thresholds (e.g., 4 different 
providers and 4 different pharmacies), time interval (e.g. over a three-month period), and drug products analyzed (e.g. Schedule II opioids) are the 
same. Meaning, the total number (or rates) of individuals who received Schedule II-V opioid prescriptions from 4 or more providers and had them filled 
at 4 or more pharmacies in a 3-month period cannot and should not be compared with the total number of individuals (or rates) who received Schedule 
II-V opioid prescriptions from 4 or more providers and had them filled at 4 or more pharmacies in a 12-month period. 
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MA Prescription Monitoring Program: January 2019 – March 2019 
County                          
(County classifications 
are by patient zip code; 
patient state must also 
= MA) 
Census  
Population 
Total 
Schedule II 
Opioid 
Prescriptions 
Total Number 
of Schedule II 
Opioid Solid 
Dosage Units 
Individuals 
Receiving 
Schedule II 
Opioid 
Prescription 
% of Individuals 
Receiving Schedule 
II Opioid 
Prescription 
 (of total 
population) 
Individuals 
with Activity 
of Concern 
Rate of Individuals 
with Activity of 
Concern  
(per 1,000) 
Barnstable 216,343 21,985 1,096,177 9,764 4.5 11 1.1 
Berkshire 127,457 12,743 646,817 5,720 4.5 < 5 NR 
Bristol 566,414 61,647 3,618,333 25,566 4.5 15 0.6 
Dukes 17,364 1,316 71,886 633 3.6 < 5 NR 
Essex 791,568 61,969 3,193,616 28,986 3.7 34 1.2 
Franklin 71,509 7,930 460,167 3,267 4.6 < 5 NR 
Hampden 473,588 49,478 2,794,248 21,225 4.5 16 0.8 
Hampshire 164,339 14,838 903,310 6,187 3.8 8 1.3 
Middlesex 1,614,538 88,464 4,473,026 44,864 2.8 37 0.8 
Nantucket 11,237 934 38,861 444 4.0 < 5 NR 
Norfolk 706,950 44,627 2,454,141 21,603 3.1 21 1.0 
Plymouth 520,230 43,983 2,517,463 20,767 4.0 5 0.2 
Suffolk 802,474 41,198 2,353,540 19,422 2.4 22 1.1 
Worcester 832,834 67,419 4,022,113 30,522 3.7 19 0.6 
MA 6,916,845 518,531 28,643,698 238,970 3.5 190 0.8 
Note 1: Individuals with activity of concern "thresholds" for this report are based ONLY on a 3-month time period; see notes on previous page; CY19-Q1 
Note 2: Counts greater than 0 but less than 5 are not reported.  Rates based on these small values also are not reported (NR). 
Note 3: Rates of individuals with activity of concern are based on the population of individuals who have received one or more Schedule II opioid prescriptions during the specified time period. 
Note 4: Totals for all counties combined will differ slightly compared to the state totals presented elsewhere because some prescription records could not be assigned a county due to inaccurate zip 
code/city town information reported to the program. 
Note 5: The total sum for the "Number of Individuals Receiving Schedule II Opioid Prescription" will be slightly different than the sum presented for the state in Figure 2 due to a small number of 
double counting of individuals moving from one county to another during the specified time period. 
Note 6: PMP data are preliminary and subject to updates. The MA PMP database is continuously updated to allow for prescription record correction data submitted by pharmacies. The data were 
extracted on 4/18/2019; Release Date: May 2019. 
Note 7: Beginning in 3rd quarter of 2016 the Department of Veteran's Affairs (VA) facilities began submitting data to the MA PMP. 
Note 8: Small Area Population Estimates 2011-2020, version 2017, Massachusetts Department of Public Health, Bureau of Environmental Health. Population estimates used for years following the 
decennial census were developed by the University of Massachusetts Donahue Institute (UMDI) in partnership with the Massachusetts Department of Public Health, Bureau of Environmental Health.  
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MA Prescription Monitoring Program Data 
Trend Analyses for Schedule II Opioids Only 
 
 Registered MassPAT providers conducted nearly 1.86 million searches in the 1st Quarter of 2019; there was an increase of 
approximately 90,000 searches from the previous quarter.   
 In the 1st Quarter of 2019 there were just over 518,000 Schedule II opioid prescriptions reported to the MA PMP; this is a 
notable decrease from the previous quarter and a 39% decrease from the 1st Quarter of 2015 (n = 841,990 Schedule II 
opioid prescriptions). 
 
Note: PMP data are subject to updates. The MA PMP database is continuously updated to allow for prescription record 
correction data submitted by pharmacies. The data for CY-2019 Q1 were extracted on 4/22/2019. 
 
 Just under 239,000 individuals in MA received prescriptions for Schedule II opioids in the 1st Quarter of 2019; this is a small, 
but notable, decrease from the previous quarter and nearly a 39% decrease from the 1st Quarter of 2015 (n = 390,532). 
 
Note: PMP data are subject to updates. The MA PMP database is continuously updated to allow for prescription record 
correction data submitted by pharmacies. The data for CY-2019 Q1 were extracted on 4/22/2019. 
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 The rate of individuals with activity of concern (also referred to as multiple provider episodes) decreased from 14.3 to 6.4 
per 1,000 individuals between CY 2013 and CY 2018, a 55% reduction in activity of concern. Between CY 2017 and CY 2018 
the rates of individuals with activity of concern increased slightly from 6.3 to 6.4 per 1,000 patients; this may reflect greater 
stability in the rate moving forward. 
 Potential contributors to the lack of continued decline of this rate may include an increase in multi-practitioner care teams, 
the continuing rise in specialty pharmacy that results in the use of multiple pharmacies by an individual to acquire 
medications, and law enforcement access to PMP data required a probable cause warrant as of 8/9/2018 (Ch. 208 of the 
Acts of 2018). 
           
        
Note: PMP data are subject to updates. The MA PMP database is continuously updated to allow for prescription record 
correction data submitted by pharmacies. The data for CY-2018 were extracted on 1/17/2019. 
 
 
Source 
 Prescription Drug Monitoring Program, Bureau of Health Professions Licensure, MDPH  
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Figure 3. Rate1 of Individuals with Activity of Concern2 in MA3
(CY 2013–2018) 
Activity of Concern
1 Rates of individuals with activity of concern are based on the population of individuals who have received one or more Schedule 
II opioid prescriptions.
2 "activity of concern"  is defined as an individual  who received prescriptions for one or more  Schedule II opioid drugs from four 
or more different prescribers and had them filled at four or more pharmacies  during the specified time period.
3 Activity of concern rates include only MA Residents
